THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
Lobbying for THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
All legislation related to Medicare site of service payment policy changes; Any legislation having to do with Medicare payments for dedicated cancer centers and hospitals, including satellite regulations; Medicare Advantage preauthorization; Medicare Advantage access issues; Cuts to services related to cancer diagnosis and treatment; Issues related to increased access to cancer detection. Issues related to "White Bagging" of pharmaceutical products; Policies related to the value of cancer care and initiatives that bend the cost curve; Issue related to site neutral payment reforms; Issues related to the FAIR Act and the work of the joint Taskforce developing a new method of cost reimbursement and federal grants
Issues related to the President's federal budget request; Funding levels for federal appropriation bills including Labor-HHS-Education, Homeland Security, Department of Defense, Commerce-Justice-Science that are related to biomedical research funding, healthcare delivery, training and education, protection of intellectual property and research. Funding for NIH and NCI.
Issues related to the reorganization of HHS and its underlying agencies: NIH, CDC, CMS, and FDA; Issues relating to clinical trials at FDA and the ability for patients to be able to access trials earlier in their treatment journey;
Issues related to clinical trial design and patients obtaining drugs sooner in the course of the trial